The authors thank the collaborators of the FAM-Study group.
Supported by BONFOR GEROK Program, Faculty of Medicine, University of Bonn, Grant Nos. O-137.0020 (ML) and O-137.0022 (MP); DFG Grant Ho1926/3-1, DFG Grant FL 658/4-1, and FL 658/4-2 Genentech, Inc. (San Francisco, CA, USA). ML is the Knoop Junior Research Fellow at St. Cross College, Oxford, UK. The authors alone are responsible for the content and writing of the paper.
Disclosure: M. Lindner, Carl Zeiss Meditec (F), Genentech (F), Heidelberg Engineering (F), Optos (F), Fresenius Medical Care (I), Allergan (R), Alimera Sciences (R); J. Nadal, None; M.M. Mauschitz, Carl Zeiss Meditec (F), Heidelberg Engineering (F), Optos (F); A. Lüning, None; J. Czauderna, Carl Zeiss Meditec (F), Heidelberg Engineering (F), Optos (F); M. Pfau, Carl Zeiss Meditec (F), Heidelberg Engineering (F), Optos (F), Bayer HealthCare (R); S. Schmitz-Valckenberg, Novartis (C, F), Allergan (F), Bayer HealthCare (F, R), Carl Zeiss Meditec (F), Formycon (F), Genentech (F), Heidelberg Engineering (F, R), Optos (F); F.G. Holz, Acucela (C, F), Alcon (C, F), Allergan (C, F), Bayer HealthCare (C, F), Carl Zeiss Meditec (F), Genentech/Roche (C, F), Heidelberg Engineering (C, F, R), Optos (F), Novartis (C, F), Boehringer Ingelheim (C), Merz (C); M. Schmid, None; M. Fleckenstein, Carl Zeiss Meditec (F), Genentech (F, R), Heidelberg Engineering (F), Optos (F), Merz (C), Bayer HealthCare (R), Novartis (R), P